Canada Travel Vaccine Market to 2032
Overview
The Canada Travel Vaccine Market is expected to reach a 1,343.54 USD Million by 2032 and is projected to grow at a CAGR of 12.47% from 2025 to 2032.
Revenue, 2024 (USD Million)
641.16
Forecast, 2032 (USD Million)
1,343.54
CAGR, 2024 - 2032
12.47%
Report Coverage
Canada
Canada Travel Vaccine Market 2018-2032 USD Million
Canada Travel Vaccine Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 641.16 USD Million
- Projected Market Size (2032): 1,343.54 USD Million
- CAGR (2025-2032): 12.47%
Key Findings of Canada Travel Vaccine Market
- The Canada Travel Vaccine Market was valued at 1,343.54 USD Million in 2024.
- The Canada Travel Vaccine Market is likely to grow at a CAGR of 12.47% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 521.99 USD Million
- The fastest growing segment Typhoid in Disease Segment grew Fastest with a CAGR of 20.82% during the forecast period from 2024 to 2032.
Canada Travel Vaccine Market Scope
Canada Travel Vaccine Market Segmentation & Scope
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Route of Administration
- Oral
- Injectable
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Canada Travel Vaccine Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 641.16 USD Million |
| Market Value in 2032 | 1,343.54 USD Million |
| CAGR (2025-2032) | 12.47% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Composition,Category,Disease,Route of Administration,Distribution Channel,Age Group,Patient Type,Gender |
Regional Insights:
-
Leading Market (2024-2032): Canada, leading in terms of revenue 641.16 USD Million in 2024
- Key Country: Canada, leading in terms of revenue with value of 641.16 USD Million in 2024.
Segments and Scope
-
Canada Travel Vaccine Market to 2032, By Type
- Inactivated Vaccines is the largest segment in Canada Travel Vaccine Market to 2032 with a revenue of 172.14 USD Million in the year 2024.
- Inactivated Vaccines is the Fastest growing segment in Canada Travel Vaccine Market to 2032 with a Growth rate of 13.67 % in forecast period 2025-2032.
-
Canada Travel Vaccine Market to 2032, By Composition
- Combination Vaccines is the largest segment in Canada Travel Vaccine Market to 2032 with a revenue of 436.32 USD Million in the year 2024.
- Combination Vaccines is the Fastest growing segment in Canada Travel Vaccine Market to 2032 with a Growth rate of 12.63 % in forecast period 2025-2032.
-
Canada Travel Vaccine Market to 2032, By Category
- Recommended Vaccine is the largest segment in Canada Travel Vaccine Market to 2032 with a revenue of 292.53 USD Million in the year 2024.
- Recommended Vaccine is the Fastest growing segment in Canada Travel Vaccine Market to 2032 with a Growth rate of 12.90 % in forecast period 2025-2032.
-
Canada Travel Vaccine Market to 2032, By Disease
- Typhoid is the largest segment in Canada Travel Vaccine Market to 2032 with a revenue of 100.55 USD Million in the year 2024.
- Typhoid is the Fastest growing segment in Canada Travel Vaccine Market to 2032 with a Growth rate of 20.82 % in forecast period 2025-2032.
-
Canada Travel Vaccine Market to 2032, By Route of Administration
- Injectable is the largest segment in Canada Travel Vaccine Market to 2032 with a revenue of 521.99 USD Million in the year 2024.
- Injectable is the Fastest growing segment in Canada Travel Vaccine Market to 2032 with a Growth rate of 12.62 % in forecast period 2025-2032.
-
Canada Travel Vaccine Market to 2032, By Distribution Channel
- B2B is the largest segment in Canada Travel Vaccine Market to 2032 with a revenue of 493.13 USD Million in the year 2024.
- B2B is the Fastest growing segment in Canada Travel Vaccine Market to 2032 with a Growth rate of 12.63 % in forecast period 2025-2032.
-
Canada Travel Vaccine Market to 2032, By Age Group
- 20-50 Years is the largest segment in Canada Travel Vaccine Market to 2032 with a revenue of 312.50 USD Million in the year 2024.
- 20-50 Years is the Fastest growing segment in Canada Travel Vaccine Market to 2032 with a Growth rate of 12.95 % in forecast period 2025-2032.
-
Canada Travel Vaccine Market to 2032, By Patient Type
- Adult is the largest segment in Canada Travel Vaccine Market to 2032 with a revenue of 283.28 USD Million in the year 2024.
- Adult is the Fastest growing segment in Canada Travel Vaccine Market to 2032 with a Growth rate of 13.14 % in forecast period 2025-2032.
-
Canada Travel Vaccine Market to 2032, By Gender
- Male is the largest segment in Canada Travel Vaccine Market to 2032 with a revenue of 330.50 USD Million in the year 2024.
- Male is the Fastest growing segment in Canada Travel Vaccine Market to 2032 with a Growth rate of 12.70 % in forecast period 2025-2032.
Canada Travel Vaccine Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Pfizer Inc. | |||
| Sanofi | |||
| GSK plc. | |||
Canada Travel Vaccine Market Geographical Sales Distribution, 2018-2032 USD Million
Canada Travel Vaccine Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Canada Travel Vaccine Market is segmented based on Segmentation Type,Composition,Category,Disease,Route of Administration,Distribution Channel,Age Group,Patient Type,Gender.
Canada Travel Vaccine Market was valued at USD 641.16(Revenue in USD Million) in 2022.
Canada Travel Vaccine Market is projected to grow at a CAGR of 12.47% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the Canada Travel Vaccine Market, holding a largest market share of 521.99 USD Million in 2024
Canada Travel Vaccine Market Scope
Canada Travel Vaccine Market Segmentation & Scope
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Route of Administration
- Oral
- Injectable
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Frequently Asked Questions
The Canada Travel Vaccine Market is segmented based on Segmentation Type,Composition,Category,Disease,Route of Administration,Distribution Channel,Age Group,Patient Type,Gender.
Canada Travel Vaccine Market was valued at USD 641.16(Revenue in USD Million) in 2022.
Canada Travel Vaccine Market is projected to grow at a CAGR of 12.47% during the forecast period of 2024 to 2032.
The estimated market value of the Canada Travel Vaccine Market for final year is USD 1,343.54 (USD Million).
Canada Travel Vaccine Market Company Profiling
Frequently Asked Questions
The Canada Travel Vaccine Market is segmented based on Segmentation Type,Composition,Category,Disease,Route of Administration,Distribution Channel,Age Group,Patient Type,Gender.
Canada Travel Vaccine Market was valued at USD 641.16(Revenue in USD Million) in 2022.
Canada Travel Vaccine Market is projected to grow at a CAGR of 12.47% during the forecast period of 2024 to 2032.
The estimated market value of the Canada Travel Vaccine Market for final year is USD 1,343.54 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.